These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3768241)

  • 1. Acute haemodynamic effects of pinacidil in man.
    Nicholls DP; Murtagh JG; Scott ME; Morton P; Shanks RG
    Br J Clin Pharmacol; 1986 Sep; 22(3):287-92. PubMed ID: 3768241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
    Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
    Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and myocardial blood flow. Profiles of pinacidil and nitroprusside in conscious dogs.
    Dubé GP; Greenfield JC
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):144-50. PubMed ID: 2021445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.
    Waite RP; Lim SL; Pang CC
    Br J Pharmacol; 1995 Oct; 116(4):2322-6. PubMed ID: 8564267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.
    Girard P; Saumet JL; Dubois F; Boissel JP
    Eur J Clin Pharmacol; 1993; 44(2):177-82. PubMed ID: 8453963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory response to vasodilator therapy in congestive cardiomyopathy.
    Rossen RM; Alderman EL; Harrison DC
    Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
    Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
    Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of guanfacine.
    Magometschnigg D; Hitzenberger G; Bonelli J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):125S-131S. PubMed ID: 6994766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure.
    Tebbe U; Wurst W; Neuhaus KL
    Eur J Clin Pharmacol; 1988; 35(3):305-8. PubMed ID: 3181283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.
    Olsen UB; Arrigoni-Martelli E
    Eur J Pharmacol; 1983 Apr; 88(4):389-92. PubMed ID: 6407852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
    Ward JW; McBurney A; Farrow PR; Sharp P
    Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.
    Sluiter HE; Huysmans FT; Thien TA; Koene RA
    Drugs; 1985; 29 Suppl 2():144-53. PubMed ID: 3987541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
    Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.